In focus · trending topic

non-obstructive HCM

1 stories · following the connections

MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients

By Nasdaq OMXApr 2, 2018, 12:31 PM UTC